SOURCE: Isys Medical, Inc. (Hathaway Corporation)

August 14, 2008 10:26 ET

ISYS (IMDN) Announces Shareholder Update

Isys Medical to File With Finra

SAINT PETERSBURG, FL--(Marketwire - August 14, 2008) - Isys Medical, Inc. (PINKSHEETS: IMDN), a next generation medical device company that seeks to make a difference in the Telemedicine and medical device industry, by offering solutions that can change or alter the way major health problems are addressed through innovative, often disruptive technologies, announces shareholder updates on the following events:

--  For providing transparency to our investors, the Company will file
    Form 211 with Finra to start the process of becoming fully reporting Pink.
    The process should begin in the next two weeks or so. If and when Finra
    approves our application, Isys will attain further visibility and market
    attention to our business, our products and our future among the early
    leaders in Telemedicine. Currently the trading will be limited until our
    application becomes effective by Finra.
    
--  The Company has been successful in completing the acquisition of the
    remaining percentage ownership of DDI. Since the initial acquisition of DDI
    by the Company two years ago, DDI has been able to attract investments and
    also world renowned diabetes medical Doctors and researchers as board
    advisors. DDI has also been successful in completing its fourth generation
    prototype device, beginning to establish relationships with major
    manufacturers, carriers and channel distributors globally. The Company is
    currently working on a final prototype which is slated for market in the
    second or third quarter of 2009, subject to FDA clearance. This will allow
    Isys Medical to produce devices that will combat the terrible effects of
    Diabetes, currently growing in epidemic rates.
    
--  To create transparency for our investors, the Company has made
    available our recent annual report for year ending March 2008, according to
    GAAP. All our future financials will be available on our website, on
    Pinksheets.com (if available) or Edgar (if possible). You can download the
    full annual report by visiting;
    http://www.isysmedical.com/financials/3.31.08.pdf.
    

The Company appreciates the understanding demonstrated by investors during this important and exciting transition. We invite you to visit our website for more information: http://www.isysmedical.com

Forward-Looking Statements

This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets.

Contact Information